Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-02

FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc., authorizing a modification to the approved gabapentin product. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)